Avidity

Avidity Biosciences' Stock Skyrockets with Bristol Myers Collaboration

Avidity's stock has experienced a significant surge after announcing a collaboration deal with pharmaceutical giant Bristol Myers, in which the two companies will work together on developing RNA-based therapies. The partnership has generated excitement among investors, leading to a notable increase in Avidity's stock value.